The protein encoded by HSRG1 (HSV-1 stimulation-related gene 1) is a virally induced protein expressed in HSV-1-infected cells. We have already reported that HSRG1 is capable of interacting with transcriptional regulator proteins. To further analyze the effects of HSRG1 on the regulation of viral gene transcription, we expressed the HSRG1 protein in transfected cells and found that it postpones the proliferation of HSV-1. CAT (chloramphenicol acetyltransferase) assays also revealed that HSRG1 reduces transcription from HSV-1 promoters. Yeast two-hybrid and immunoprecipitation assays indicated that HSRG1 interacts with Cyclin T2, the regulatory subunit of P-TEFb, which is required for transcription elongation by RNA Pol II (RNAP II), and that amino acid residues 1-420 in Cyclin T2 are important for binding with HSRG1. Fluorescence assays suggested that the cellular localizations of those two proteins are influenced by their interaction. Further analyses with CAT assays revealed that HSRG1 inhibits the transcriptional activation by Cyclin T2 of viral promoters. Our results suggested that the inhibitory effects of HSRG1 on viral replication and proliferation are probably induced by its binding to Cyclin T2. Therefore, it is likely that HSRG1 inhibits viral gene transcriptional elongation by interacting with Cyclin T2. 
Herpes simplex virus 1 (HSV-1), a DNA virus possessing both complicated transcriptional mechanisms and genome structure [1] , can interact with a latently or lytically infected host [2, 3] . Viral components interact with host structural proteins, as well as particular cellular proteins expressed during HSV-1 infection. These interactions can affect the function of cellular components, thereby altering biological processes [4, 5] . Existing data demonstrate that cellular expression profiles change in HSV-1-infected cells and have different effects on viral proliferation [6] . Our earlier work focused on analyzing changes in gene expression induced by HSV-1 infection in human fibroblasts; HSRG1, encoded by the HSV-1 stimulation-related gene, is one of these proteins [7] . HSRG1 is expressed 2 h after infection and is classified as a SAND protein family member [8] , containing a eukaryotic conserved domain [9] of unknown biological function. Our earlier work also indicated that HSRG1 interacts with the SV40 large T-antigen (LT), altering transcriptional regulation of LT from the SV40 promoter [10] . These results suggested that HSRG1 could interact with transcriptional regulatory proteins. In the present study, we screened candidate cellular proteins that could interact with HSRG1 by a yeast two-hybrid assay, and our results showed that Cyclin T2 was one such protein. Cyclin T2 is an important transcriptional regulator. Previous studies have shown that Cyclin T2 binds with CDK9 to form the P-TEFb complex (positive transcription elongation factor b, P-TEFb), which regulates transcriptional elongation of RNA polymerase II (RNAP II) by phosphorylating transcription-related factors [11] . RNAP II has an important and non-specific role in the gene transcription processes [12] , and the interaction of HSRG1 with the Cyclin T2 subunit of the P-TEFb complex indicates that the cellular and viral gene transcriptional process might be affected by this interaction during HSV-1 infection. In the present study, we investigated the possible mechanisms and biological significance of HSRG1 in HSV-1 infection.
Materials and methods

Cells and viruses
China hamster ovarian cancer cells (CHO-K1) and African green monkey kidney cells (Vero) from our laboratory were grown in F12 supplemented with 10% (v/v) of fetal bovine serum in T-75 cell culture containers or six-well plates. HSV-1 (F strain) was also provided from our laboratory.
Plasmid construction
Recombination plasmid pcDNA3-CycT2a was constructed by ligating the Cyclin T2 gene into the eukaryotic expression plasmid, pcDNA3.1 (Invitrogen). The gene encoding Cyclin T2 was obtained by PCR amplification with primers CycT2a-F1 and CycT2a-R1 (Table 1) . Eukaryotic expression plasmid pcDNA3-HSRG1, expressing HSRG1, has already been constructed in our laboratory [10] . Recombination plasmid pGADT7-HSRG1 was constructed by ligating the HSRG1 gene (amplified with primers HSRG1-F1 and HSRG1-R1) into the pGADT7 vector (Clontech). Furthermore, pGBKT7-CycT2a, pGBKT7-T2a-250A, pGBKT7-T2a-300A, and pGBKT7-T2a-420A were constructed separately by inserting the sequence of Cyclin T2 cDNA, or sequences encoding Cyclin T2 amino acids 1−250, 1−300, or 1-420, into the pGBKT7 vector (Clontech). The Cyclin T2 cDNA and deletion fragments were amplified with primers CycT2-F, CycT2-R; CycT2-F, CycT2-250A-R; CycT2-F, CycT2-300A-R; CycT2-F; and CycT2-420A-R, respectively (Table 1 ). In addition, pRed-HSRG1 was constructed by inserting the HSRG1 gene (primers CycT2-F2 and CycT2-R2) into the pDsRed-N1 vector (Clontech). Prokaryotic expression plasmid pGEX-4T-CycT2a expressing the Cyclin T2a cDNA was donated by Professor Matija Peterlin. Plasmids pCAT-α4, pCAT-TK, and pCAT-gC plasmids were constructed in this laboratory [13] . All recombinant plasmids were confirmed by enzymatic digestion and DNA sequencing. Table 1 Primers for PCR amplification   Primer name  Sequence (5′ to 3′)   HSRG1-F1  5′-ATTGAATTCATGGAGCTCGGAGGAGAC-3′  HSRG1-R1  5′-ACAGAATTCGAGTCCAGTGAACAAGCC-3′  HSRG1-F2  5′-TATGAATTCGGATGGAGCTCGGAGGA-3′  HSRG1-R2 5′
Plaque assay
Vero cells were transfected with pcDNA3-HSRG1 or pcDNA3, incubated for 24 h at 37°C, and then infected with HSV-1 at MOI 0.5 (multiplicity of infection (MOI)=ratio of infectious virus particles to cells) for absorption for 30 min at 37°C. Viruses were harvested at 24 h and the virus titer was tested by a virus plaque assay and counting plaque forming units (PFU) mL −1 of samples. The results were presented as mean values obtained from three independent experiments.
Yeast two-hybrid assay
Y187 yeast cells transformed with the recombinant plasmid pGADT7-HSRG1 were fused with AH109 yeast cells transformed with recombinant plasmid pGBKT7-CycT2a or pGBKT7-T2a-250A/300A/420A in accord with standard protocols (http://www.clontech.com/products/detail.asp? product_id=206489&tabno=6). The resulting clones were inoculated into two volumes of YPDA medium for incubation for 20-24 h at 30°C. The fused culture was inoculated onto SD/-Leu-Trp plates for incubation for one week at 30°C. Colonies were inoculated onto SD/-His-Leu-Trp and SD/-Ade-His-Leu-Trp plates and incubated for one week at 30°C, and positive clones were screened.
β-galactosidase (β-gal) activity detection
Clones were picked and inoculated into 5 mL SD/-Leu-Trp liquid medium with shaking (200 r min −1 ) overnight at 30°C
and then trans-inoculated into YPDA medium with continued shaking for 3-5 h at 30°C. A 600 values were recorded. Yeast cells were collected when the A 600 value reached 0.5-0.8. Samples were mixed with 4 mg mL −1 ortho-Nitrophenyl-β-galactoside (ONPG) and incubated at 30°C until the solution turned a yellow color. The reaction time was recorded. The values for 420 nm light absorption were recorded using a spectrophotometer after removing cell debris. β-D-galactosidase content was calculated by the following formula: β-D-galactosidase units=1000×A 420 /t× 5×A 600 (where A 600 is equal to the A 600 absorption value of 1 mL culture and t is the reaction time). The experiment was repeated three times with positive (pGBK-p53+pACT-LT) and negative (pGBK-Lam+pACT-LT) controls.
Cell transfection
CHO cells, grown in six-well plates to 90% confluence, were transfected using Lipofectamine 2000 (Invitrogen) and the appropriate plasmid, according to the manufacturer's instructions (http://tools.invitrogen.com/content/sfs/manuals/ lf2k_reverse_transfection_web.pdf).
Preparation of Cyclin T2 antibodies
The E. coli BL21 bacterial strain was transfected with the pGEX-4T-CycT2a plasmid expressing the GST-CycT2a fusion protein following IPTG induction. The purified protein was obtained by excising an SDS-PAGE gel band that contained a protein with the corresponding molecular weight and electroeluting the protein. The same volumes of the purified GST-CycT2a fusion protein and complete Freund's adjuvant were emulsified and mixed for multiple abdominal subcutaneous injections into Kunming mice. The mice were boosted with incomplete Freund's adjuvant emulsions at week 2 and 4. Blood was taken from the eyeball two weeks after the 3rd immunization for preparation of Cyclin T2 antiserum.
Immunoprecipitation and Western blotting
Vero cells incubated for 36 h after co-transfection with pcDNA3-HSRG1 and pcDNA3-CycT2a plasmids were rinsed with PBS three times, scraped, treated with RIPA lytic solution (150 mmol L −1 NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mmol L −1 Tris·HCl, pH 7.5) and incubated in an ice bath for 30 min. Protein supernatants were collected by centrifugation. An aliquot of the supernatant was reserved as an input sample. Immunoprecipitation of HSRG1 and Cyclin T2 was carried out according to standard procedures. Antibodies against HSRG1 were added to the remaining lysate supernatants and incubated for 2 h at 37°C. Immune complexes were precipitated by incubation with Protein A agarose (Beyotiome). Following incubation, tubes were centrifuged and the beads were washed in lysis buffer. Equal volumes of protein precipitant were subjected to 10% SDS-PAGE and transferred to a PVDF membrane followed by blocking with 5% BSA-TTBS. Western blot analysis was performed using HSRG1 or Cyclin T2 antisera as primary antibodies and sheep anti-mouse IgG-HRP as the secondary antibody for DAB reaction.
Chloramphenicol acetyltransferase (CAT) activity analysis
CHO cells were transfected and incubated for 48 h at 37°C.
The CAT and β-galactosidase activities in CHO cell extracts in each group were detected by the CAT enzyme assay system and the β-gal enzyme assay system, respectively, in accord with standard protocols (Promega). β-gal activity values were used to normalize CAT activity values. The relative CAT activity in each experimental group was calculated by defining the CAT activity values detected by co-transfection of pcDNA3 plasmid and CAT reporter gene expression plasmids as 100. The results were presented as the mean values obtained from three independent experiments.
Analysis of protein localization
Vero cells incubated for 40 h after co-transfection with pRed-HSRG1 and pEGFP-CycT2 plasmids were examined with an immunofluorescent microscope. Photographs were taken and merged to analyze the locations of fluorescent fusion proteins.
Statistical analysis
All data were statistically analyzed according to standard protocols. Results are expressed as means±SD. Statistical significance was determined using two-way analysis of variance and the Student's t-test using SPSS 11.0 software. P-values<0.05 were considered statistically significant.
Results
Expression of HSRG1 delays the proliferation of HSV-1
HSRG1 is a host protein expressed during HSV-1 infection.
To analyze the effect of HSRG1 on HSV-1 proliferation, Western blot analysis was performed on extracts from transfected Vero cells using HSRG1 antisera as the primary antibody. The results showed that HSRG1 was expressed in pcDNA3-HSRG1-transfected cells ( Figure 1A ). Plaque assays were then used to analyze the effects of HSRG1 on virus titer. Vero cells transfected with pcDNA3-HSRG1 or pcDNA3 were infected with HSV-1 at an MOI of 0.5, 24 h after transfection. Viruses were harvested at 12 or 24 h. The results showed that virus titers in cells transfected with pcDNA3-HSRG1 were lower than in the control group, indicating that high expression of HSRG1 delayed the proliferation of HSV-1 ( Figure 1B ).
HSRG1 inhibits transcriptional elongation efficiency on HSV-1 α4, TK, and gC promoters
To analyze the effect of HSRG1 on virus proliferation, CAT assays were carried out to detect the transcriptional regulatory effect of HSRG1 on HSV-1 gene promoters. The eu- karyotic expression plasmid pcDNA3-HSRG1 was cotransfected with reporter plasmids pCAT-α4, pCAT-TK, or pCAT-gC into CHO-K1 cells.
CAT activity was measured to analyze the effects of HSRG1 on different viral gene promoters. The results showed that HSRG1 protein had different inhibitory effects on HSV-1 immediate-early, early, and late gene transcription ( Figure 2 ) and that this effect was somewhat dose-dependent.
HSRG1 interacts with Cyclin T2a protein
To analyze proteins interacting with HSRG1, we selected a number of possible candidate proteins using yeast twohybrid experiments. A human liver cell cDNA library was screened using HSRG1 as the bait protein (Table 2) . Cyclin T2 was one of the candidate proteins. Cyclin T2 contains several conserved structural domains, including an N-terminal Cyclin box, a histidine rich region, and a leucine rich region. These are important for the formation of the P-TEFb complex by Cyclin T2/CDK9 dimerization and for binding with RNAP II. In this study, recombinant plasmids pGBKT7-CycT2a, pGBKT7-T2a-250A, pGBKT7-T2a-300A, and pGBKT7-T2a-420A were constructed by ligating the sequences of Cyclin T2 and a series of truncated fragments of its N-terminal 250, 300, and 420 amino acids ( Figure 3A) into the pGBKT7 vector. AH109 yeast cells transfected with these recombinant plasmids were fused with Y187 yeast cells transfected with pGADT7-HSRG1. The results suggested that potential interactions existed between HSRG1 and multiple regions of Cyclin T2 ( Figure 3B ). β-galactosidase activity of yeast clones grown on SD/-AdeHis-Leu-Trp plates was detected, suggesting that amino acids 1-250 and 300-420 of Cyclin T2a have significant contributions to protein interactions ( Figure 3D ). Yeast two-hybrid experiments showed that the physical interaction of HSRG1 and Cyclin T2 is mediated by amino acids 1-250 and 300-420 of Cyclin T2. The former contains the cyclin box, a conserved domain that could bind to CDK9. To further verify the relationship between these two proteins in cells, immunoprecipitation was performed using anti-HSRG1 antiserum in Vero cells transfected with pcDNA3-HSRG1 and pcDNA3-CycT2a. Cyclin T2 complexed with HSRG1 was detected by co-immunoprecipitation, followed by Western blotting with anti-Cyclin T2 antiserum ( Figure 3C ). These results confirmed the interaction between HSRG1 and Cyclin T2. Additionally, a yeast two-hybrid β-gal assay also revealed the amino acid regions responsible for the interaction between HSRG1 and Cyclin T2 ( Figure 3D ).
HSRG1 protein colocalizes with Cyclin T2 protein in living cells
To verify the interaction between HSRG1 and Cyclin T2 in living cells, recombinant plasmids pRed-HSRG1 and pEGFP-T2a were constructed and transfected into Vero cells. HSRG1 was expressed as a fusion protein with red fluorescent protein, and Cyclin T2a was expressed as a fusion protein with green fluorescent protein. The distribution of fluorescent proteins was observed at 48 h. As shown in Figure 4 , Cyclin T2a-GFP localized in the nucleus and HSRG1-RFP localized in the cytoplasm when plasmids pRed-HSRG1 or pEGFP-T2a were transfected alone ( Figure  4A ). However, colocalization of both signals was observed in both the nucleus and the cytoplasm when the two plasmids were co-transfected into Vero cells ( Figure 4B ). Taken together, these experiments suggested that the HSRG1 protein interacts with Cyclin T2 protein in cells, and that the cellular localizations of these two proteins were changed to some extent by these interactions.
HSRG1 can block the promotion of Cyclin T2-mediated transcriptional activation of HSV-1 virus promoters
Our experiments indicated that HSRG1 could interact with Cyclin T2. Furthermore, CAT assays showed inhibitory effects of HSRG1 on several viral gene promoters. Considering the biological significance of Cyclin T2 in the P-TEFb transcriptional elongation factor complex, CAT reporter gene activity was assessed in CHO-K1 cells co-transfected with pcDNA3-HSRG1 or pcDNA3-CycT2a together with CAT reporter plasmids to analyze the effect of HSRG1 on transcriptional promotion by Cyclin T2. The results revealed that transcriptional activation of immediate-early, early, and late HSV-1 promoters was upregulated in cells transfected with pcDNA3-CycT2a, whereas, in cells co-transfected with pcDNA3-HSRG1 and pcDNA3-CycT2a, the presence of HSRG1 was able to block Cyclin T2-mediated transcriptional activation of different viral promoters ( Figure 5A-C) . Thus, HSRG1, a protein expressed in the early stages of HSV-1 infection, binds with Cyclin T2, the regulatory subunit of the P-TEFb transcriptional elongation complex to downregulate Cyclin T2-mediated activation of viral promoters during HSV-1 infection. It is likely that HSRG1 functions to inhibit viral proliferation by inhibiting activation of viral promoters. 
Discussion
Proteins induced by viral infection have been intensively studied [6, 7, 10] and the functions of these proteins have been gradually clarified. HSRG1, belonging to the conserved SAND protein family, is one of the proteins upregulated in early stages of HSV-1 infection. As a member of the SAND family, it is important to understand the functions of HSRG1. We previously found that HSRG1 specifically interacts with amino acids 132-450 of the SV40 large T antigen, and that transcriptional activity of SV40 promoters activated by large T was inhibited by HSRG1 [10] . We suggested that HSRG1 might have a role in cellular transcriptional regulation. The results presented here indicate that upregulation of HSRG1 inhibits proliferation of HSV-1. In addition, CAT assays found that HSRG1 inhibits transcriptional elongation efficiency on the HSV-1 α4, TK, and gC promoters and that this effect was somewhat dosedependent. These results suggested that HSRG1 has an important role in viral gene transcription. Transcription in eukaryotic cells involves three major steps: initiation, elongation, and termination. After successful initiation of RNA synthesis, RNA pol II can pause, be arrested, pass through terminator sequences, or terminate transcription. The post-initiation processivity of RNA pol II is controlled by both negative and positive factors. The P-TEFb complex is composed of a catalytic subunit (cyclin-dependent kinase CDK9) and a subunit, Cyclin T2. Cyclin T2 is proposed to facilitate the transition from abortive to productive elongation by phosphorylating the C-terminal domain (CTD) of the largest subunit of RNA pol II [12] . Cyclin T2 has two forms, termed T2a and T2b, which likely arise by alternative splicing of the primary transcript. Although they share the N-terminus, they have different carboxy termini [14] , both of which can bind with CDK9 to form a P-TEFb complex to promote transcriptional efficiency by productive transcriptional elongation. Like all Cyclin T proteins, Cyclin T2a contains two conserved domains: the Cyclin box, formed by 250 amino acids that can bind with CDK9, and the histidine-rich stretch, which binds to the CTD of RNAP II and direct the transcriptional activity of the P-TEFb complex. In addition to these two domains, Kurosu et al. [15] found a leucine-rich region next to the cyclin boxes in Cyclin T2, which are responsible for maintaining appreciable transcriptional activity and binding RNAP II via its CTD. It has been suggested that Cyclin T2a exerts its positive effect by interacting with CDK9 and RNAP II via different domains to shorten their spatial distance, promoting the phosphorylation of the largest subunit CTD of RNA pol II by CDK9. In this study, a Figure 5B ), or CAT-gC ( Figure 5C ) was co-transfected into CHO cells with different combinations of 1 μg pcDNA3-HSRG1 or 1 μg pcDNA3-CycT2a. The total amount of transfected DNA was kept constant by the addition of pcDNA3 in every well. Samples were harvested 48 h after transfection. The relative CAT activity in each experimental group was calculated by defining the CAT activity values detected by the combination of pcDNA3 plasmid and CAT reporter gene expression plasmid transfection as 100, n=3. * indicates P<0.05.
yeast two-hybrid analysis showed that multiple regions of Cyclin T2a are important for interaction with HSRG1, including the N-terminal Cyclin box domain. Fluorescent protein localization experiments analyzed the effect of this interaction on the spatial location of these proteins. These results established that HSRG1 and Cyclin T2a localized in the cytoplasm and nucleus separately when plasmids were transfected alone, while the nuclear localization of Cyclin T2 was partly blocked by HSRG1. Furthermore, some HSRG1 was transferred to the nucleus by Cyclin T2 when the plasmids were co-transfected. Therefore, it is reasonable to speculate that the biological function of Cyclin T2a might be affected by binding with HSRG1. The effect of HSRG1 on transcriptional promotion by Cyclin T2a was analyzed.
The results demonstrated that HSRG1 could reverse the positive transcriptional regulation of Cyclin T2 and could inhibit the expression of multiple HSV-1 genes, to varying degrees. This inhibitory effect could be explained by HSRG1 blocking or depleting Cyclin T2 such that transcriptional efficiency was downregulated because of reduced levels of P-TEFb complexes. Considering the association of HSV-1 infection and high expression of HSRG1, it is likely that HSRG1 constitutes a cellular defense against viruses by limiting viral gene duplication in infected cells.
